New product vs established brand investment?
A trade-off you no longer have to make in this changing world
2nd November 2020
A trade-off you no longer have to make in this changing world
2nd November 2020
Truly achieving a patient-focused cultural shift means pharma leaders must build momentum behind the necessity of partnering with patients to capture and incorporate their valuable insights, say Dawn Lobban and Peter Impey
3rd September 2020
O4 Research's Moneeb Saddiq and Andrea Parke consider whether the patient-centricity story is complete or still evolving
3rd September 2020
Eliran Malki, co-founder and CEO of Belong.Life, explores what pharma can do to engage the modern patient
3rd September 2020
ICON's Gretchen Goller on getting the patient perspective on clinical trial participation
3rd September 2020
Keeping the needs of patients as a guiding principle has been key to Kyowa Kirin's recent success, says Richard Johnson
3rd September 2020
On January 30, 2020, the WHO declared the novel acute respiratory infection caused by the “SARS-CoV-2” virus, termed “Coronavirus Disease-2019 (COVID-19)” as a Public Health Emergency of International Concern.{9} As of July 20, 2020, over 14 million people worldwide are confirmed to be infected, leading to increasing fatality rates.{10}
12th August 2020
Creating space for open dialogue between patients and healthcare professionals
20th July 2020